Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06913998

The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
65 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
1 Year – 25 Years
Healthy volunteers
Not accepted

Summary

The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test. The result of the gene test will be analyzed and compared with other clinical data.

Detailed description

In inflammatory bowel disease (IBD), thiopurines play an important role in maintenance of steroid-free remission but possess risk of life-threatening neutropenia, which is associated with gene variants of NUDT15 in Asians. In order to better incorporate thiopurines in clinical practice, the investigators aim to summarize the prevalence and impacts of NUDT15 variation in IBD in Taiwan. The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test. The result of the gene test will be analyzed and compared with other clinical data.

Conditions

Timeline

Start date
2023-12-27
Primary completion
2026-01-01
Completion
2026-11-01
First posted
2025-04-06
Last updated
2025-04-08

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06913998. Inclusion in this directory is not an endorsement.